We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Transarterial chemoembolization (TACE) for colorectal liver metastases-current status and critical review.
- Authors
Massmann, Alexander; Rodt, Thomas; Marquardt, Steffen; Seidel, Roland; Thomas, Katrina; Wacker, Frank; Richter, Götz; Kauczor, Hans; Bücker, Arno; Pereira, Philippe; Sommer, Christof
- Abstract
Background: Transarterial liver-directed therapies are currently not recommended as a standard treatment for colorectal liver metastases. Transarterial chemoembolization (TACE), however, is increasingly used for patients with liver-dominant colorectal metastases after failure of surgery or systemic chemotherapy. The limited available data potentially reveals TACE as a valuable option for pre- and post-operative downsizing, minimizing time-to-surgery, and prolongation of overall survival after surgery in patients with colorectal liver only metastases. Purpose: In this overview, the current status of TACE for the treatment of liver-dominant colorectal liver metastases is presented. Critical comments on its rationale, technical success, complications, toxicity, and side effects as well as oncologic outcomes are discussed. The role of TACE as a valuable adjunct to surgery is addressed regarding pre- and post-operative downsizing, conversion to resectability as well as improvement of the recurrence rate after potentially curative liver resection. Additionally, the concept of TACE for liver-dominant metastatic disease with a focus on new embolization technologies is outlined. Conclusions: There is encouraging data with regard to technical success, safety, and oncologic efficacy of TACE for colorectal liver metastases. The majority of studies are non-randomized single-center series mostly after failure of systemic therapies in the 2nd line and beyond. Emerging techniques including embolization with calibrated microspheres, with or without additional cytotoxic drugs, degradable starch microspheres, and technical innovations, e.g., cone-beam computed tomography (CT) allow a new highly standardized TACE procedure. The real efficacy of TACE for colorectal liver metastases in a neoadjuvant, adjuvant, and palliative setting has now to be evaluated in prospective randomized controlled trials.
- Subjects
CHEMOEMBOLIZATION; LIVER metastasis; COLON cancer treatment; ONCOLOGIC surgery complications; RANDOMIZED controlled trials; HEPATIC arterial infusion chemotherapy; THERAPEUTICS
- Publication
Langenbeck's Archives of Surgery, 2015, Vol 400, Issue 6, p641
- ISSN
1435-2443
- Publication type
Article
- DOI
10.1007/s00423-015-1308-9